Publication:
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome

dc.contributor.authorNaranjo, Laura (57199155062)
dc.contributor.authorStojanovich, Ljudmila (55917563000)
dc.contributor.authorDjokovic, Aleksandra (42661226500)
dc.contributor.authorAndreoli, Laura (23110534400)
dc.contributor.authorTincani, Angela (7005623740)
dc.contributor.authorMaślińska, Maria (12782206900)
dc.contributor.authorSciascia, Savino (26421432900)
dc.contributor.authorInfantino, Maria (36965614500)
dc.contributor.authorGarcinuño, Sara (57222357108)
dc.contributor.authorKostyra-Grabczak, Kinga (57213618422)
dc.contributor.authorManfredi, Mariangela (8927547000)
dc.contributor.authorRegola, Francesca (57199841161)
dc.contributor.authorStanisavljevic, Natasa (36163559700)
dc.contributor.authorMilanovic, Milomir (7003857551)
dc.contributor.authorSaponjski, Jovica (56629875900)
dc.contributor.authorRoccatello, Dario (7005747589)
dc.contributor.authorCecchi, Irene (57191501152)
dc.contributor.authorRadin, Massimo (57190688571)
dc.contributor.authorBenucci, Maurizio (6602125228)
dc.contributor.authorPleguezuelo, Daniel (57192685701)
dc.date.accessioned2025-06-12T12:37:24Z
dc.date.available2025-06-12T12:37:24Z
dc.date.issued2022
dc.description.abstractBackground: Antiphospholipid syndrome (APS) is a multisystemic autoimmune disorder characterized by thrombotic events and/or gestational morbidity in patients with antiphospholipid antibodies (aPL). In a previous single center study, APS-related clinical manifestations that were not included in the classification criteria (livedo reticularis, thrombocytopenia, leukopenia) were associated with the presence of circulating immune-complexes (CIC) formed by beta-2-glycoprotein-I (B2GP1) and anti-B2GP1 antibodies (B2-CIC). We have performed a multicenter study on APS features associated with the presence of B2-CIC. Methods: A multicenter, cross-sectional and observational study was conducted on 303 patients recruited from six European hospitals who fulfilled APS classification criteria: 165 patients had primary APS and 138 APS associated with other systemic autoimmune diseases (mainly systemic lupus erythematosus, N=112). Prevalence of B2-CIC (IgG/IgM isotypes) and its association with clinical manifestations and biomarkers related to the disease activity were evaluated. Results: B2-CIC prevalence in APS patients was 39.3%. B2-CIC-positive patients with thrombotic APS presented a higher incidence of thrombocytopenia (OR: 2.32, p=0.007), heart valve thickening and dysfunction (OR: 9.06, p=0.015) and triple aPL positivity (OR: 1.83, p=0.027), as well as lower levels of C3, C4 and platelets (p-values: <0.001, <0.001 and 0.001) compared to B2-CIC-negative patients. B2-CIC of IgM isotype were significantly more prevalent in gestational than thrombotic APS. Conclusions: Patients with thrombotic events and positive for B2-CIC had lower platelet count and complement levels than those who were negative, suggesting a greater degree of platelet activation. Copyright © 2022 Naranjo, Stojanovich, Djokovic, Andreoli, Tincani, Maślińska, Sciascia, Infantino, Garcinuño, Kostyra-Grabczak, Manfredi, Regola, Stanisavljevic, Milanovic, Saponjski, Roccatello, Cecchi, Radin, Benucci, Pleguezuelo, Serrano, Shoenfeld and Serrano.
dc.identifier.urihttps://doi.org/10.3389/fimmu.2022.957201
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85138790944&doi=10.3389%2ffimmu.2022.957201&partnerID=40&md5=3c57fda474f50b12ea982b06c9040e33
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/3278
dc.subjectantiphospholipid syndrome
dc.subjectcirculating immune-complexes
dc.subjectcomplement factors
dc.subjectplatelets
dc.subjectthrombocytopenia
dc.titleCirculating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
dspace.entity.typePublication

Files